Safety and Effectiveness of PCSK9 Inhibitors in Orthotopic Heart Transplant Patients

被引:0
|
作者
Sammour, Yasser [1 ]
Austin, Bethany A. [1 ]
Borkon, Michael [1 ]
Everley, Mark P. [1 ]
Fendler, Timothy J. [1 ]
Khumri, Taiyeb M. [1 ]
Lawhorn, Stephanie L. [1 ]
Magalski, Anthony [1 ]
Nassif, Michael E. [1 ]
Vodnala, Deepthi [1 ]
Kao, Andrew C. [1 ]
Sperry, Brett W. [1 ]
机构
[1] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
054
引用
收藏
页码:S22 / S22
页数:1
相关论文
共 50 条
  • [11] PCSK9 inhibitors
    Gencer, Baris
    Lambert, Gilles
    Mach, Francois
    SWISS MEDICAL WEEKLY, 2015, 145
  • [12] Safety and Tolerability of PCSK9 Inhibitors: Current Insights
    Kosmas, Constantine E.
    Skavdis, Andreas
    Sourlas, Andreas
    Papakonstantinou, Evangelia J.
    Genao, Edilberto Pena
    Uceta, Rogers Echavarria
    Guzman, Eliscer
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2020, 12 : 191 - 202
  • [13] PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety
    Roth, Eli M.
    Davidson, Michael H.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2018, 19 : S31 - S46
  • [14] Efficacy and Safety of PCSK9 Inhibitors in Stroke Prevention
    Moustafa, Bayan
    Testai, Fernando
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (11):
  • [15] Heart to heart with PCSK9
    Chemello, Kevin
    Jaafar, Ali K.
    Lambert, Gilles
    EUROPEAN HEART JOURNAL, 2021, 42 (32) : 3091 - 3093
  • [16] PCSK9 inhibitors in HIV patients with dyslipidemia
    Datla, S.
    Ali, B.
    Sattouf, Z.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [17] Cost-effectiveness with PCSK9 inhibitors: a matter of costs
    Drexel, Heinz
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2018, 4 (01) : 23 - 24
  • [18] Cost-effectiveness of PCSK9 Inhibitors Proof in the Modeling
    Bonow, Robert O.
    Harrington, Robert A.
    Yancy, Clyde W.
    JAMA CARDIOLOGY, 2017, 2 (12) : 1298 - 1299
  • [19] Cost-effectiveness evaluation of the use of PCSK9 inhibitors
    Civeira, Fernando
    Pedro-Botet, Juan
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2021, 68 (06): : 369 - 371
  • [20] A Comparative Effectiveness Review of Benefits and Harms of PCSK9 Inhibitors
    McDonagh, Marian
    Peterson, Kim
    Fazio, Sergio
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 387 - 388